November 10, 2016 07:36 AM EST
R&D

Bris­tol-My­ers scores fresh brag­ging rights with PhI­II gas­tric can­cer suc­cess for Op­di­vo

Arsalan Arif

Founder

Bris­tol-My­ers Squibb has grabbed some bad­ly need­ed new brag­ging rights in the check­point space, an­nounc­ing Thurs­day morn­ing that in­ves­ti­ga­tors reaped pos­i­tive over­all sur­vival da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the ...

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

Sage shakes up se­nior man­age­ment, slash­es pipeline, sheds 33% of staff

FDA de­lays col­orec­tal can­cer de­ci­sion for Am­gen's Lumakras, a set­back in race with Bris­tol My­ers

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times